VANNI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 167
AS - Asia 160
EU - Europa 142
SA - Sud America 46
AF - Africa 2
Totale 517
Nazione #
US - Stati Uniti d'America 163
CN - Cina 55
SG - Singapore 48
BR - Brasile 38
DE - Germania 37
IT - Italia 32
RU - Federazione Russa 30
FI - Finlandia 23
HK - Hong Kong 23
VN - Vietnam 19
GB - Regno Unito 7
AR - Argentina 5
CH - Svizzera 4
TR - Turchia 4
AT - Austria 3
CA - Canada 3
ID - Indonesia 3
AZ - Azerbaigian 2
FR - Francia 2
JP - Giappone 2
SE - Svezia 2
ZA - Sudafrica 2
BG - Bulgaria 1
CO - Colombia 1
EC - Ecuador 1
HN - Honduras 1
IE - Irlanda 1
IN - India 1
KG - Kirghizistan 1
KZ - Kazakistan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 517
Città #
Dallas 43
Munich 28
Ashburn 27
Singapore 25
Beijing 23
Hong Kong 23
Helsinki 16
New York 12
Ho Chi Minh City 11
Los Angeles 10
Moscow 10
Pavia 10
Shanghai 9
Boardman 8
Turku 7
Buffalo 4
Düsseldorf 4
Florence 4
Milan 4
Redondo Beach 4
São Paulo 4
Ankara 3
Brugherio 3
Frankfurt am Main 3
Lugano 3
Baku 2
Camaçari 2
Curitiba 2
Jakarta 2
Johannesburg 2
Orem 2
Santa Clara 2
Stockholm 2
Tianjin 2
Tokyo 2
Vienna 2
Washington 2
Almaty 1
Atlanta 1
Ayapel 1
Belém 1
Bishkek 1
Brooklyn 1
Cambé 1
Carapicuíba 1
Chengdu 1
Chennai 1
Chicago 1
Da Nang 1
Denver 1
Dongguan 1
Dublin 1
Flores da Cunha 1
General Pacheco 1
Goodyear 1
Guacara 1
Haiphong 1
Hefei 1
Houston 1
Hải Dương 1
Ibiúna 1
Iguape 1
Indaiatuba 1
Ingeniero Gustavo André 1
Jinan 1
Juiz de Fora 1
Kayseri 1
London 1
Lorena 1
Louisville 1
Magé 1
Messias 1
Milagro 1
Montreal 1
Moreno 1
Nanjing 1
Nuremberg 1
Ottawa 1
Ouro Preto do Oeste 1
Paracatu 1
Paris 1
Passo Fundo 1
Phoenix 1
Phủ Lý 1
Piracicaba 1
Poplar 1
Porto Nacional 1
Portsmouth 1
Pouso Alegre 1
Quilmes Oeste 1
Quảng Nam Province 1
Reston 1
Ribeirão Preto 1
Rio de Janeiro 1
Rome 1
Salvador 1
San Jose 1
San Justo 1
San Pedro Sula 1
Santa Fe 1
Totale 385
Nome #
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis 82
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms 77
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 70
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms 60
Isolated congenital asplenia: An overlooked cause of thrombocytosis 57
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms 56
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score 44
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study 44
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms 40
Totale 530
Categoria #
all - tutte 2.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.315


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202313 0 0 0 0 0 0 0 0 0 0 13 0
2023/202478 7 10 5 2 10 27 9 2 1 2 1 2
2024/2025218 7 7 1 26 1 11 19 8 46 15 28 49
2025/2026221 26 36 55 49 48 7 0 0 0 0 0 0
Totale 530